Literature DB >> 6279225

Prevalence of antibodies to poliovirus in 1978 among subjects aged 0-88 years.

M Roebuck, R Chamberlain.   

Abstract

The antibody state of a population aged 6 months to 88 years to poliovirus types 1, 2, and 3 was determined by examining 919 sera collected in Lancashire, London, and southern and south-east England. In subjects aged over 2 years the immune state was surprisingly uniform, although the older patients had probably acquired practically all their antibodies as a result of natural infection and those under 16 through vaccination. at least 95% had detectable antibodies to at least one poliovirus type and about 60% to all three types, with the exception of a cohort of children born between 1963 and 1968, in whom the proportions were about 80% and 40% respectively. These children were born around the time of the changeover from inactivated to oral vaccine, when immunisation rates were low and there was confusion over the number of doses required. These results indicate that a complete course of vaccine or a booster dose at or around school-leaving age is necessary.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 6279225      PMCID: PMC1496662          DOI: 10.1136/bmj.284.6317.697

Source DB:  PubMed          Journal:  Br Med J (Clin Res Ed)        ISSN: 0267-0623


  6 in total

1.  Immunity of children to diphtheria, tetanus, and poliomyelitis.

Authors:  D Bainton; M Freeman; D I Magrath; F Sheffield; J W Smith
Journal:  Br Med J       Date:  1979-03-31

2.  Sero-immunity to poliovirus in children and young women: England 1972-4.

Authors:  P P Mortimer; P Cunningham
Journal:  J Hyg (Lond)       Date:  1975-04

3.  Poliomyelitis and the social environment.

Authors:  A B HILL; W J MARTIN
Journal:  Br Med J       Date:  1949-08-13

4.  Protection against poliomyelitis.

Authors:  A A Codd; E White
Journal:  Lancet       Date:  1977-11-19       Impact factor: 79.321

5.  Childhood immunization 1979. Disturbing statistics for metropolitan Sydney.

Authors:  M A Menser; E Collins; S W Wu; J Hudson
Journal:  Med J Aust       Date:  1980-08-09       Impact factor: 7.738

6.  Serological epidemiology of poliomyelitis; distribution of immunity to poliomyelitis virus.

Authors:  R J FALLON
Journal:  Lancet       Date:  1956-01-14       Impact factor: 79.321

  6 in total
  8 in total

Review 1.  Poliomyelitis vaccination.

Authors:  R Chamberlain
Journal:  Br Med J (Clin Res Ed)       Date:  1987-07-18

2.  Seroimmunity to poliovirus in Poitiers, France.

Authors:  G Agius; S Ranger; E Baillargeau; C Rouches; M Castets
Journal:  Eur J Clin Microbiol       Date:  1986-04       Impact factor: 3.267

3.  Prevalence of antibody to poliovirus in England and Wales 1984-6.

Authors:  P M White; J Green
Journal:  Br Med J (Clin Res Ed)       Date:  1986-11-01

4.  Poliomyelitis immunity status at different intervals from vaccination.

Authors:  E Bellelli; U Bracchi; M L Tanzi; G Benaglia; G Montanarini
Journal:  Eur J Epidemiol       Date:  1986-09       Impact factor: 8.082

5.  The environment in childhood and risk of motor neuron disease.

Authors:  C N Martyn; C Osmond
Journal:  J Neurol Neurosurg Psychiatry       Date:  1992-11       Impact factor: 10.154

6.  Paralytic poliomyelitis in England & Wales, 1970-84.

Authors:  N T Begg; R Chamberlain; M Roebuck
Journal:  Epidemiol Infect       Date:  1987-08       Impact factor: 2.451

Review 7.  Is EU/EEA population protected from polio?

Authors:  Dre Nijsten; P Carrillo-Santisteve; A Miglietta; J Ruitenberg; P L Lopalco
Journal:  Hum Vaccin Immunother       Date:  2015-04-21       Impact factor: 3.452

8.  PREVALENCE OF NEUTRALIZING ANTIBODIES AGAINST POLIOVIRUS 1, 2, AND 3 IN HEALTHCARE PROFESSIONALS AGED 20-50 YEARS.

Authors:  José Cassio de Moraes; Maria Josefa Penon Rujula; Marcelo Otsuka
Journal:  Rev Paul Pediatr       Date:  2021-02-03
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.